Effect of Prenatal Dexamethasone on Sex-specific Changes in Embryonic and Placental Growth

  • Yun, Hyo Jung (Department of Anatomy, Embryology laboratory, Brain Korea 21 PLUS Project for Medical Science, Yonsei University of College of Medicine) ;
  • Lee, Ji-Yeon (Department of Anatomy, Embryology laboratory, Brain Korea 21 PLUS Project for Medical Science, Yonsei University of College of Medicine) ;
  • Kim, Jongsoo (Department of Anatomy, Embryology laboratory, Brain Korea 21 PLUS Project for Medical Science, Yonsei University of College of Medicine) ;
  • Kim, Myoung Hee (Department of Anatomy, Embryology laboratory, Brain Korea 21 PLUS Project for Medical Science, Yonsei University of College of Medicine)
  • 투고 : 2014.03.21
  • 심사 : 2014.03.25
  • 발행 : 2014.03.31

초록

To understand the effect of prenatal stress on sex-specific changes in embryonic and placental growth, a synthetic glucocorticoid (dexamethasone) was administered intraperitoneally at a dosage of 1 mg/kg body weight (BW) (Dex1) or 10 mg/kg BW (Dex10) to pregnant ICR mice at the gestational days 7.5, 8.5 and 9.5 post coitum (p.c.). Embryos and placentas were then harvested at days 11.5 and 18.5 p.c., and their body weight and size were measured following the determination of sex through PCR using Sry specific primers in tail tissues. As a result, female embryos presented reduced fetal body weight and size in Dex1- and Dex10-treated groups than those of control group at the embryonic day 11.5 p.c. Interestingly, the growth seems to be recovered at day 18.5 as there was no difference in growth between control and dexamethasone treated groups. In the case of males, Dex1 induced a decrease in fetal weight in day 11.5 and this pattern was maintained until day 18.5, whereas their growth was not affected by Dex10 treatment. Placental growth showed similar patterns to fetal growth in both sexes but the extent of reduction was not statistically significant in most cases. Placental weights in Dex1- and Dex10-treated group were decreased significantly in male only. The results imply that the effect of prenatal stress is largely sex dependent due to different strategies for growth and survival in a stressful environment.

키워드

참고문헌

  1. Ain R, Canham LN, Soares MJ. Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the Akt signaling pathway. J Endocrinol. 2005. 185: 253-263. https://doi.org/10.1677/joe.1.06039
  2. Bale TL. Sex differences in prenatal epigenetic programming of stress pathways. Stress. 2011. 14: 348-356. https://doi.org/10.3109/10253890.2011.586447
  3. Beversdorf DQ, Manning SE, Hillier A, Anderson SL, Nordgren RE, Walters SE, Nagaraja HN, Cooley WC, Gaelic SE, Bauman ML. Timing of prenatal stressors and autism. J Autism Dev Disord. 2005. 35: 471-478. https://doi.org/10.1007/s10803-005-5037-8
  4. Cottrell EC, Seckl JR. Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci. 2009. 3: 19.
  5. Cuffe JS, Dickinson H, Simmons DG, Moritz KM. Sex specific changes in placental growth and MAPK following short term maternal dexamethasone exposure in the mouse. Placenta. 2011. 32: 981-989. https://doi.org/10.1016/j.placenta.2011.09.009
  6. Di Renzo GC, Rosati A, Sarti RD, Cruciani L, Cutuli AM. Does fetal sex affect pregnancy outcome? Gend Med. 2007. 4: 19-30. https://doi.org/10.1016/S1550-8579(07)80004-0
  7. Gerardin P, Wendland J, Bodeau N, Galin A, Bialobos S, Tordjman S, Mazet P, Darbois Y, Nizard J, Dommergues M, Cohen D. Depression during pregnancy: is the developmental impact earlier in boys? A prospective case-control study. J Clin Psychiatry. 2011. 72: 378-387. https://doi.org/10.4088/JCP.09m05724blu
  8. Hewitt DP, Mark PJ, Waddell BJ. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology. 2006. 147: 5568-5574. https://doi.org/10.1210/en.2006-0825
  9. Kim SH, Lee J-Y, Park SJ, Kim MH. Effects of dexamethasone on embryo development and Hox gene expression patterns in mice. J Exp Biomed Sci. 2011. 17: 231-238.
  10. Lee JY, Park SJ, Kim SH, Kim MH. Prenatal administration of dexamethasone during early pregnancy negatively affects placental development and function in mice. J Anim Sci. 2012. 90: 4846-4856. https://doi.org/10.2527/jas.2012-5090
  11. Reynolds RM. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner. Psychoneuroendocrinology. 2013. 38: 1-11. https://doi.org/10.1016/j.psyneuen.2012.08.012
  12. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet. 2001. 2: 538-548.
  13. van Os J, Selten JP. Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands. Br J Psychiatry. 1998. 172: 324-326. https://doi.org/10.1192/bjp.172.4.324
  14. Xu D, Chen M, Pan XL, Xia LP, Wang H. Dexamethasone induces fetal developmental toxicity through affecting the placental glucocorticoid barrier and depressing fetal adrenal function. Environ Toxicol Pharmacol. 2011. 32: 356-363. https://doi.org/10.1016/j.etap.2011.08.003